Apellis Pharmaceuticals, Inc. (FRA:1JK)
18.34
+0.75 (4.28%)
At close: Dec 5, 2025
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of €2.57 billion as of December 5, 2025. Its market cap has decreased by -24.54% in one year.
Market Cap
2.57B
Enterprise Value
2.57B
Revenue
866.28M
Ranking
n/a
PE Ratio
67.03
Stock Price
€18.34
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from 593.77M to 2.57B, an increase of 332.83%. That is a compound annual growth rate of 19.89%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.46B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |